Segall Bryant & Hamill, LLC Johnson & Johnson Transaction History

Segall Bryant & Hamill, LLC

$5.57 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$155.75 - $174.48 $3.22 Million - $3.61 Million	-20,691 Reduced 6.89%	279,599 $43.5 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $842,905 - $907,126	-5,461 Reduced 1.79%	300,290 $49.7 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $68,576 - $81,838	454 Added 0.15%	305,751 $47.4 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $421,005 - $472,488	2,628 Added 0.87%	305,297 $53.9 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $122,772 - $136,614	-761 Reduced 0.25%	302,669 $49.4 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $1.09 Million - $1.21 Million	-6,503 Reduced 2.1%	303,430 $53.9 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $1.8 Million - $2.04 Million	-11,354 Reduced 3.53%	309,933 $54.9 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $664,105 - $736,849	-4,259 Reduced 1.31%	321,287 $55 Million
Q3 2021 Nov 03, 2021	BUY	$161.5 - $179.47 $985,473 - $1.1 Million	6,102 Added 1.91%	325,546 $52.6 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $1.7 Million - $1.83 Million	-10,674 Reduced 3.23%	319,444 $52.6 Million
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $1.29 Million - $1.44 Million	-8,432 Reduced 2.49%	330,118 $54.3 Million
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $668,548 - $767,384	-4,876 Reduced 1.42%	338,550 $53.3 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $1.62 Million - $1.77 Million	11,512 Added 3.47%	343,426 $51.1 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $2.06 Million - $2.49 Million	-16,015 Reduced 4.6%	331,914 $46.7 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $1.05 Million - $1.46 Million	-9,472 Reduced 2.65%	347,929 $45.6 Million
Q4 2019 Feb 11, 2020	SELL	$127.5 - $146.44 $4.03 Million - $4.63 Million	-31,595 Reduced 8.12%	357,401 $52.1 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $1.31 Million - $1.46 Million	-10,302 Reduced 2.58%	388,996 $50.3 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $14 Million - $15.4 Million	-106,976 Reduced 21.13%	399,298 $0
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $1.61 Million - $1.79 Million	12,795 Added 2.59%	506,274 $0
Q4 2018 Feb 15, 2019	BUY	$122.84 - $147.84 $3.47 Million - $4.18 Million	28,245 Added 6.07%	493,479 $63.7 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $1.1 Million - $1.29 Million	-9,011 Reduced 1.9%	465,234 $0
Q2 2018 Aug 08, 2018	BUY	$119.4 - $131.76 $6.27 Million - $6.91 Million	52,476 Added 12.44%	474,245 $0
Q1 2018 May 16, 2018	SELL	$125.1 - $148.14 $2.68 Million - $3.17 Million	-21,402 Reduced 4.83%	421,769 $0
Q4 2017 Feb 15, 2018	SELL	$131.22 - $143.62 $1.62 Million - $1.77 Million	-12,348 Reduced 2.71%	443,171 $0
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $59 Million - $61.7 Million	455,519	455,519 $0

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account